The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
Clinical trial NCT06546540 · RECRUITING
Trial details
- NCT number
- NCT06546540
- Sponsor
- Peking University Third Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-08
- Primary completion
- 2025-12-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.